Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
Background Biomarker for usefulness in diagnosing advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is expected. In order to discover novel biomarkers for NAFLD and its pathogenesis, we performed matabolomics screening. Methods (1) The initial cohort was 44 NAFLD patients. (2) This valid...
Gespeichert in:
Veröffentlicht in: | Journal of gastroenterology 2013-12, Vol.48 (12), p.1392-1400 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!